Arabic Arabic English English French French German German
dark

Forge Biologics Closes $80 Million in Additional Financing to Accelerate Planned CDMO Expansion

Forge Biologics announced today 2022 manufacturing expansion plans to meet the growing demand for gene therapy manufacturing. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Travere Therapeutics Provides Corporate Update and 2022 Outlook

Next Post

TISSIUM Appoints Ruth Krestin as Vice President of Portfolio Strategy

Related Posts
Total
0
Share